RESUMEN
Klebsiella oxytoca is primarily a health care-associated pathogen acquired from environmental sources. During October 2006-March 2011, a total of 66 patients in a hospital in Toronto, Ontario, Canada, acquired class A extended-spectrum ß-lactamase-producing K. oxytoca with 1 of 2 related pulsed-field gel electrophoresis patterns. New cases continued to occur despite reinforcement of infection control practices, prevalence screening, and contact precautions for colonized/infected patients. Cultures from handwashing sinks in the intensive care unit yielded K. oxytoca with identical pulsed-field gel electrophoresis patterns to cultures from the clinical cases. No infections occurred after implementation of sink cleaning 3×/day, sink drain modifications, and an antimicrobial stewardship program. In contrast, a cluster of 4 patients infected with K. oxytoca in a geographically distant medical ward without contaminated sinks was contained with implementation of active screening and contact precautions. Sinks should be considered potential reservoirs for clusters of infection caused by K. oxytoca.
Asunto(s)
Brotes de Enfermedades , Contaminación de Equipos , Desinfección de las Manos/instrumentación , Infecciones por Klebsiella/epidemiología , Klebsiella oxytoca/efectos de los fármacos , beta-Lactamasas/biosíntesis , Infección Hospitalaria/epidemiología , Infección Hospitalaria/microbiología , Electroforesis en Gel de Campo Pulsado , Desinfección de las Manos/métodos , Humanos , Control de Infecciones , Unidades de Cuidados Intensivos , Infecciones por Klebsiella/microbiología , Klebsiella oxytoca/clasificación , Klebsiella oxytoca/enzimología , Klebsiella oxytoca/genética , Klebsiella oxytoca/aislamiento & purificación , Ontario/epidemiología , Abastecimiento de Agua , beta-Lactamasas/genéticaRESUMEN
New Delhi metallo-ß-lactamase-1 (NDM-1) is a recently identified metallo-ß-lactamase that confers resistance to carbapenems and all other ß-lactam antibiotics, with the exception of aztreonam. NDM-1 is also associated with resistance to many other classes of antibiotics. The enzyme was first identified in organisms isolated from a patient in Sweden who had previously received medical treatment in India, but it is now recognized as endemic throughout India and Pakistan and has spread worldwide. The gene encoding NDM-1 has been found predominantly in Escherichia coli and Klebsiella pneumoniae. We describe the isolation NDM-1-producing organisms from two patients in Toronto, Ontario. To the best of our knowledge, this is the first report of an organism producing NDM-1 that was locally acquired in Canada. We also discuss the evidence that NDM-1 can affect bacterial species other than E. coli and K. pneumoniae, the limited options for treatment and the difficulty laboratories face in detecting organisms that produce NDM-1.
Asunto(s)
Morganella morganii/aislamiento & purificación , Proteus mirabilis/aislamiento & purificación , beta-Lactamasas/orina , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Morganella morganii/enzimología , Ontario , Reacción en Cadena de la Polimerasa , Proteus mirabilis/enzimología , Orina/microbiología , Resistencia betalactámica , beta-Lactamasas/genéticaRESUMEN
We identified 69 Staphylococcus aureus isolates that were erythromycin intermediate as reported by the Vitek-1 system using the GPS-105 card. Of the 57 strains that were available for further testing, all were erythromycin resistant by broth microdilution and the Phoenix system, while the Vitek-2 system identified 55 of 57 strains (96%) as erythromycin resistant. The majority of isolates (54 of 57 [95%]) exhibited the inducible MLS (macrolide-lincosamide-streptogramin family) phenotype, as shown by the double-disk test. We recommend that all S. aureus strains determined as erythromycin intermediate by the Vitek-1 system be interpreted as resistant to erythromycin.